At St. Louis-based Ascension, pharmacy is not treated as a separate business line. It is seen as the connective tissue of care — a way to keep patients healthy long after they have left the hospital. “We’re a collection of…

The FDA has approved Lynkuet, a 60-milligram capsule therapy from Bayer, for the treatment of moderate to severe hot flashes due to menopause. Lynkuet is the first dual neurokinin-1 and neurokinin-3 receptor antagonist approved for this indication. The once-daily, nonhormonal…

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and Kenvue, alleging the companies deceptively marketed Tylenol to pregnant women “despite known dangers to unborn children,” according to an Oct. 26 press release. The lawsuit claims…

A new California law will require pharmacist-led medication reviews for high-risk hospital patients at discharge starting Jan. 1, according to a Cedars-Sinai news release. The law, promoted by Cedars-Sinai, aims to prevent harmful medication errors when patients leave the hospital,…

The pharmacy benefits landscape is changing quickly, prompting health systems to adapt. With rising drug costs, regulations, and increasing demands for transparency, many are rethinking their reliance on legacy PBM contracts and are exploring modular, tech-enabled models that provide greater…

The Cigna Group’s Evernorth division introduced a rebate-free pharmacy benefit model that it says will lower medication costs and simplify drug pricing. The model removes the traditional post-purchase rebate structure by applying negotiated drug discounts upfront, according to an Oct. 27…

If you undergo a surgical procedure or are admitted to a hospital for nearly any serious condition, you are likely to receive various generic injectable drugs. From blood thinners to antibiotics to anesthetics, these essential medicines are used every day…

Health systems across the country are rethinking what pharmacy leadership looks like. The most sought-after roles today go beyond dispensing medications; they center on finance, data analytics, payer relations and technology integration, reflecting pharmacy’s growing role in both clinical and…

The FDA has reapproved GlaxoSmithKline’s belantamab mafodotin-blmf as of Oct. 23 for adults with relapsed or refractory multiple myeloma — three years after the drug was voluntarily withdrawn from the market due to unsuccessful trial results. The B-cell maturation antigen-directed…

Nearly 75% of active drug shortages in the U.S. began in 2022 or earlier, with some persisting for more than five years. According to a report from the American Society of Health-System Pharmacists released in September, the number of active…